Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytokines are a large, diverse family of secreted signaling proteins and glycoproteins released primarily by immune cells to mediate intercellular communication, regulate immunity, inflammation, hematopoiesis, tissue repair, and homeostasis. They act through high-affinity cell surface receptors, initiating intracellular signaling cascades such as JAK/STAT and NF-κB to modulate gene expression and cellular responses. Dysregulation of cytokine networks is linked to a range of diseases including inflammation, cancer, infection, and autoimmune disorders. Because "multiple cytokines" refers collectively to this entire class, it is not a precise drug target; rather, individual cytokines (like interleukin-6, tumor necrosis factor alpha, or interferon gamma) are specific and actionable molecular targets in research and therapy.
Inhibition of cytokine production or signaling (e.g., JAK/STAT inhibitors, anti-cytokine antibodies); Cytokine receptor blockade; Immunomodulation via regulation of cytokine expression or release
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cytokines.